mitomycin has been researched along with Diabetes Mellitus, Type 1 in 4 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Excerpt | Relevance | Reference |
---|---|---|
"Hypoglycemia is associated with cognitive dysfunction, but the exact mechanisms have not been elucidated." | 1.91 | Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage. ( Chen, Z; Huang, C; Huang, L; Ke, S; Lin, L; Liu, L; Wang, L; Wu, Y, 2023) |
"Mitomycin C treatment of MNC from IDDM patients abolished insulin secretion inhibition in recipient mice." | 1.29 | Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients. ( Arata, M; Basabe, JC; Fabiano de Bruno, L; Gagliardi, G; Goncalvez Volpini, W; Quintans, CJ, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lin, L | 1 |
Chen, Z | 1 |
Huang, C | 1 |
Wu, Y | 1 |
Huang, L | 1 |
Wang, L | 1 |
Ke, S | 1 |
Liu, L | 1 |
Babiker, S | 1 |
Elsayed, ME | 1 |
Dhaygude, A | 1 |
Madgula, I | 1 |
Arata, M | 1 |
Fabiano de Bruno, L | 1 |
Goncalvez Volpini, W | 1 |
Gagliardi, G | 1 |
Quintans, CJ | 1 |
Basabe, JC | 1 |
Dispenzieri, A | 1 |
Loprinzi, CL | 1 |
4 other studies available for mitomycin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Cognitive Dysfunction; Diabetes Mellitus, Type 1; Glucos | 2023 |
A complex case of haemodialysis induced increased intraocular pressure.
Topics: Acetazolamide; Antihypertensive Agents; Diabetes Mellitus, Type 1; Glaucoma, Neovascular; Humans; In | 2019 |
Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients.
Topics: Adolescent; Animals; Antibiotics, Antineoplastic; Cell Transplantation; Cells, Cultured; Child; Chil | 1995 |
Chemotherapy-induced insulin-dependent diabetes mellitus.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Dexamethasone; | 1997 |